{"id":"tp-44812","type":"article-newspaper","title":"FDA Extends Agios’ Mitapivat Review for Sickle Cell Disease by Three Months","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/44812","datePublished":"2026-10-30T15:16:15.000Z","dateModified":"2026-10-30T15:16:15.000Z","language":"en","abstract":"The updated PDUFA goal date is Feb. 1, 2027, moved from Nov. 1, 2026. The FDA accepted the application for Priority Review in July.","section":"Regulation","references":[]}